Alterity Therapeutics Ltd (ATH)

0.017
+0.001(+6.25%)
  • Volume:
    116,036
  • Bid/Ask:
    0.016/0.017
  • Day's Range:
    0.016 - 0.017

ATH Overview

Prev. Close
0.016
Day's Range
0.016-0.017
Revenue
10K
Open
0.017
52 wk Range
0.013-0.035
EPS
-0.01
Volume
116,036
Market Cap
40.92M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
2,176,655
P/E Ratio
-
Beta
0.68
1-Year Change
-48.48%
Shares Outstanding
2,406,874,578
Next Earnings Date
Aug 30, 2022
What is your sentiment on Alterity Therapeutics?
or
Market is currently closed. Voting is open during market hours.

Alterity Therapeutics Ltd Company Profile

Alterity Therapeutics Ltd Company Profile

Employees
0
Market
Australia

Alterity Therapeutics Limited is an Australia-based biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company's lead product candidate, ATH434, is being used for the treatment of various Parkinson's disease, Dementia with lewy bodies (DLB) as well as various forms of atypical Parkinsonism, such as Multiple System Atrophy (MSA). ATH434, is a set of molecules designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. The Company also has a drug discovery platform generating chemical to intercede in disease processes. ATH434 has been granted Orphan Drug designation for the treatment of Multiple System Atrophy.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyBuySell
Technical IndicatorsStrong BuyStrong BuyStrong BuySellStrong Sell
SummaryStrong BuyStrong BuyStrong BuyNeutralStrong Sell